Major League Baseball announced a few moments ago that it will immediately begin testing for HGH in the minor leagues. That sound you hear is a thousand writers and commentators preparing their “good for baseball for finally getting tough” column/blog post/TV talking head spot. Don’t buy a bit of it.
For starters, this is not news. It was leaked back in February that this would be happening. Now it is happening. Anyone who calls this move “surprising” is not really following PED stories.
More significantly, the HGH test baseball will be using is the same one mentioned back in February: the test a British rugby league used to catch one of its players. What will likely be left out of these new columns is that (a) the rugby player was the first one in several years of alleged HGH testing to ever be caught; and (b) he was only caught because testing officials received a tip the night before that the player had received a big honking shipment of HGH. If the rugby league was really using the test, it never caught anyone through random testing.
Which can be explained by one of two things, neither of which speak well of the test in question: (1) the test gives almost universal false negatives; or (2) because HGH’s duration in the blood stream — 24-48 hours according to most experts — is too short for random testing to ever work. Shoe leather and stool pigeons are the only way anyone has ever been caught for using HGH, and that’s likely to remain the case.
Finally, because Major League Baseball does not have the stomach to engage the MLBPA on implementation of the test, the testing will be limited to the minor leagues and will likely stay that way for the foreseeable future.
The upshot: No one except the most clueless will ever be caught by this test and the big league players from whom the PED hawks think we need protection will never be tested. Other than that, fabulous.
At least, if you like exercises in public relations.
A free agent pitcher on the decline coming off of major surgery and still looking for work on February 12 isn’t exactly the definition of Big News. But as newspaper men have known for ages, if you make a bit of information sound cool enough, it becomes news.
Or, in some cases, you can make a lack of information sound cool. If you hear about a trade rumor but aren’t able to actually find out the identity of one of the teams, call it a “mystery team.” Oooh, isn’t that dramatic? Aren’t you privy to all kinds of intrigue! Or, how about this: that free agent on the decline is doing what scores of other ballplayers looking for work are doing and is working out in the Phoenix area, trying to catch on someplace. That’s kind of boring. And you don’t even know who he’s auditioning for or where to boot. Man, that’s not the sort of information that’s gonna be fun or interesting to report.
There. “Secret location.” THAT sounds exciting. THAT separates this bit of news from the dog-bites-man “baseball player playing baseball” non-story. *reporter cracks knuckles* “Now to sit back and wait for the plaudits for my amazing reporting skills to come rolling in.”
CC Sabatha made headlines in October when he abruptly left the Yankees to go into alcohol rehab. After a month there he came back and gave interviews about his decision and his battle with the bottle and then disappeared into the offseason the way most players do.
He emerged the other day and spoke with the New York Daily News’ Mark Feinsand and says that he’s ready for baseball once again. Indeed, in some ways he’s more ready now than he usually is by mid February. He’s been throwing bullpen sessions for the past three weeks — he normally waits until he gets to Tamps — and he says his troublesome knee is feeling good.
Sabathia will turn 36 during the season. In 2015 he was 6-10 with a 4.73 ERA in 29 starts and posted his lowest strikeout rate in a decade. Late in the season, however, with the help of a knee brace, he was at his most effective in some time. He won’t need to return to 2008 form in order to help the Yankees this season, but he will need to look more like he did in September if he is to help the Yankees to the playoffs.
The Mets are currently enjoying the spoils of the best young rotation in the game, but the big question is whether this is just a brief window or the start of sustained success. Given the huge prices on the free agent market, it’s going to be next to impossible to keep the band together, but at least one member of the rotation is open to sticking around for the long-term.
While there haven’t been any talks yet, All-Star right-hander Jacob deGrom told Kevin Kernan of the New York Post that he could see himself discussing an extension with the Mets.
“I’m a little bit older, so I might be more willing to do something like that,’’ deGrom told The Post at Mets pre-camp. “You just have to look at what is fair so both sides get a decent deal. It’s something I’d have to look into and make sure I agree with it.’’
It makes sense from deGrom’s perspective. He broke into the majors later than most prospects, so he’ll be 28 this June. Depending on whether he qualifies as a Super Two, he’ll be arbitration-eligible for the first time after either 2016 or 2017. Either way, he’s under team control through 2020, which means that he’s currently on track to hit free agency after his age-32 season. The market might not be kind to him even if he manages to stay healthy, so it could behoove him to get as much guaranteed money as possible right now. The Mets could always decide to play things year-to-year, but perhaps deGrom would be willing to settle for a discount in order to get them to buy out a free agent year or two. It’s a really interesting situation to think about, but odds are the two sides will wait on contract talks until he’s arbitration-eligible for the first time.
DeGrom owns a 2.61 ERA in 52 starts over his first two seasons in the majors. Among starters, only Zack Greinke, Jake Arrieta, and Clayton Kershaw have a lower ERA since the start of 2014.
The Royals and third baseman Mike Moustakas have avoided arbitration by agreeing to a two-year, $14.3 million deal, reports Jon Heyman of MLB Network.
The deal, which was initially discussed last month, buys out Moustakas’ final two years of arbitration. Jeffrey Flanagan of MLB.com reports that it’s believed he’ll make $5.6 million in 2016 and $8.7 million in 2017.
The 27-year-old Moustakas posted an underwhelming .668 OPS over his first four seasons in the majors, but he enjoyed a big postseason in 2014 before breaking out last season by batting .284/.348/.470 with 22 home runs and 82 RBI.